The 2016 American College of Chest Physicians treatment guidelines for venous thromboembolism: a review and critical appraisal

Internal and Emergency Medicine

Volumn 11, Issue 8, 2016, Pages 1031-1035

  Douketis, James Demetrios ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Anticoagulants; Practice guideline; Treatment; Venous thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT;

HUMAN; PRACTICE GUIDELINE; PROCEDURES; STANDARDS; THORAX SURGERY; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

ANTICOAGULANTS; ASPIRIN; GUIDELINES AS TOPIC; HUMANS; THORACIC SURGERY; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84991745801     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-016-1553-0     Document Type: Review

References (28)

1. Hirsh J, Hull RD (1986) Treatment of venous thromboembolism. Chest 89(5 Suppl):426S–433S
2. Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H et al (2016) Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 149(2):315–352
3. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ et al (2012) Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e419S–e494S
4. Castellucci LA, Cameron C, Le Gal G, Rodger MA, Coyle D, Wells PS et al (2014) Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis. JAMA 312(11):1122–1135
5. Buller HR (2014) Edoxaban versus warfarin for venous thromboembolism. N Engl J Med 370(1):80–81
6. Dentali F, Di Minno MN, Gianni M, Ambrosino P, Squizzato A, Ageno W (2015) Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature. Intern Emerg Med 10(4):507–514
7. Kahn SR, Shapiro S, Wells PS, Rodger MA, Kovacs MJ, Anderson DR et al (2014) Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet 383(9920):880–888
8. Enden T, Haig Y, Klow NE, Slagsvold CE, Sandvik L, Ghanima W et al (2012) Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 379(9810):31–38
9. Lee AY, Kamphuisen PW, Meyer G, Bauersachs R, Janas MS, Jarner MF et al (2015) Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial. JAMA 314(7):677–686
10. Baglin T, Bauer K, Douketis J, Buller H, Srivastava A, Johnson G et al (2012) Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH. J Thromb Haemost 10(4):698–702
11. Tosetto A, Iorio A, Marcucci M, Baglin T, Cushman M, Eichinger S et al (2012) Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost 10(6):1019–1025
12. Rodger MA, Kahn SR, Wells PS, Anderson DA, Chagnon I, Le Gal G et al (2008) Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. CMAJ 179(5):417–426
13. Eichinger S, Heinze G, Jandeck LM, Kyrle PA (2010) Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model. Circulation 121(14):1630–1636
14. Douketis J, Tosetto A, Marcucci M, Baglin T, Cushman M, Eichinger S et al (2010) Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism. Ann Intern Med 153(8):523–531
15. Palareti G, Cosmi B, Legnani C, Antonucci E, De Micheli V, Ghirarduzzi A et al (2014) D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study. Blood 124(2):196–203
16. Kearon C, Ageno W, Cannegieter SC, Cosmi B, Geersing GJ, Kyrle PA et al (2016) Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. J Thromb Haemost 14(7):1480–1483
17. Baglin T, Douketis J, Tosetto A, Marcucci M, Cushman M, Kyrle P et al (2010) Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis. J Thromb Haemost 8(11):2436–2442
18. Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P et al (2012) Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 367(21):1979–1987
19. Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M et al (2012) Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 366(21):1959–1967
20. Wiener RS, Schwartz LM, Woloshin S (2013) When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found. BMJ 347:f3368
21. Carrier M, Righini M, Le Gal G (2012) Symptomatic subsegmental pulmonary embolism: what is the next step? J Thromb Haemost 10(8):1486–1490
22. Vedantham S, Goldhaber SZ, Kahn SR, Julian J, Magnuson E, Jaff MR et al (2013) Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis. Am Heart J. 165(4):523–530
23. Vedantham S, Kahn SR, Goldhaber SZ, Comerota AJ, Parpia S, Meleth S et al (2016) Endovascular therapy for advanced post-thrombotic syndrome: proceedings from a multidisciplinary consensus panel. Vasc Med 21(4):400–407
24. Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J et al (2014) Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 370(15):1402–1411
25. Kline JA, Nordenholz KE, Courtney DM, Kabrhel C, Jones AE, Rondina MT et al (2014) Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial. J Thromb Haemost 12(4):459–468
26. Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M, Investigators M (2013) Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial). Am J Cardiol 111(2):273–277
27. Ageno W, Beyer-Westendorf J, Garcia DA, Lazo-Langner A, McBane RD, Paciaroni M (2016) Guidance for the management of venous thrombosis in unusual sites. J Thromb Thrombolysis 41(1):129–143
28. Liew A, Douketis J (2016) Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment? Intern Emerg Med. doi:10.1007/s11739-016-1463-1